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As there is an increasing number of multicentre lung imaging studies with MRI in patients,
dedicated reference phantoms are required to allow for the assessment and comparison of
image quality in multi-vendor and multi-centre environments. However, appropriate phan-
toms for this purpose are so far not available commercially. It was therefore the purpose of
this project to design and apply a cost-effective and simple to use reference phantom which
addresses the specific requirements for imaging the lungs with MRI.
Methods
The phantom was designed to simulate 4 compartments (lung, blood, muscle and fat) which
reflect the specific conditions in proton-MRI of the chest. Multiple phantom instances were
produced and measured at 15 sites using a contemporary proton-MRI protocol designed for
an in vivo COPD study at intervals over the course of the study. Measures of signal- and
contrast-to-noise ratio, as well as structure and edge depiction were extracted from conven-
tionally acquired images using software written for this purpose.
Results
For the signal to noise ratio, low intra-scanner variability was found with 4.5% in the lung
compartment, 4.0% for blood, 3.3% for muscle and 3.7% for fat. The inter-scanner variability
was substantially higher, with 41%, 32%, 27% and 32% for the same order of compart-
ments. In addition, measures of structure and edge depiction were found to both vary signifi-
cantly among several scanner types and among scanners of the same model which were
equipped with different gradient systems.
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Conclusion
The described reference phantom reproducibly quantified image quality aspects and
detected substantial inter-scanner variability in a typical pulmonary multicentre proton MRI
study, while variability was greater in lung tissue compared to other tissue types. Accord-
ingly, appropriate reference phantoms can help to detect bias in multicentre in vivo study
results and could also be used to harmonize equipment or data.
Introduction
Today, in vivo magnetic resonance imaging (MRI) of the lung is increasingly performed in pul-
monary diseases such as cystic fibrosis (CF) [1–3], Chronic Obstructive Pulmonary Disease
(COPD) [4–7] and chronic thromboembolic pulmonary hypertension [8]. It is also used in
epidemiological whole-body MRI studies [9]. In addition, the number of large cohort studies
employing computed tomography (CT) or MRI in lung diseases is on the rise. In this context,
proton MRI can provide valuable image-based biomarkers (visual scores or quantitative soft-
ware based metrics) reflecting disease-related structural lung characteristics, such as the extent
of airway wall thickening, bronchiectases, mucus plugging, and emphysema, or functional
characteristics such as perfusion impairment. A multicentre study design is often inevitable,
requiring the use of different scanners leading to heterogeneous image quality. Consequently,
the quantification of image quality becomes increasingly important to address potential bias
introduced by imaging with different systems.
For lung tissue, little is known about the impact of different MRI scanners on the assess-
ment of morphological and functional aspects. MRI devices from different manufacturers and
production series are expected to provide substantial differences in image quality, but there is
limited data available on the magnitude of variability in determinants of image quality such as
Signal to Noise Ratio (SNR) or Contrast to Noise Ratio (CNR). Since image interpretation in
lung MR studies is complicated by poor signal intensity due to the low proton density and
inhomogeneity of the magnetic field (B0) intrinsic to lung tissue, characteristics of scanner
design are likely to have high impact on analysis and interpretation of lung imaging studies
[10–12]. Further, multicentre studies may take significant time due to continuous patient
recruitment, which presents the additional task of ensuring consistent image quality over the
course of the trial with appropriate reference phantoms being scanned at regular intervals as
performed, for example in the COPDgene study [13] or in the European cystic fibrosis clinical
trials network (SCIFI CF) [14]. Generally, such variability cannot be fully compensated by cali-
bration and could therefore influence the interpretation of study results, for example when
correlating imaging biomarkers with other clinical tests.
While recent CT-based studies on COPD [13] or CF [1] applied commercial reference
phantoms, appropriate phantoms for lung MRI are not yet commercially available. Reference
phantoms designed for the quality assurance of MRI studies have, until now, mainly been
developed with focus on cerebral imaging, along with software which provides fully automated
image processing [15–19], especially for functional MRI (fMRI) [20]. However, none have
been designed with the challenges of proton lung MRI studies in mind, such as low proton
density and local magnetic field inhomogeneities, due to the rarity of lung imaging in MRI.
Besides, varying capabilities of different MRI scanners in the context of lung imaging have not
been investigated systematically before. Consequently, the aim of this study was to build a
cost-effective and simple to use reference phantom specifically designed for proton MRI of the
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lung. In addition, this is the first phantom study to comparatively assess intra- and inter-scan-
ner variability of SNR and CNR of different structural and functional proton-MRI sequences
for current lung MRI in 15 different MRI scanners.
Methods
Prerequisites
The available and suitable scanners for lung MRI [21] span a range of available models and dif-
fer in B0 field strength (1.5T and 3.0T), gradient strength (between 33mT/m and 45mT/m),
signal reception hardware (both the number of reception coils and receive amplifiers) as well
as length and width of the magnet bore. The bore dimensions, both length and diameter, have
a significant effect on the B0 field homogeneity at a distance to the isocentre, which in turn
causes distortions. Due to the magnetic field inhomogeneities in the lungs, which also lead to
very short T2 relaxation time, B0 is additionally important, while the gradient amplitudes
available are mainly relevant since they determine the available echo time (TE) and thus the
degree of T2-weighting [22, 23]. Finally, due to the large field of view required for lung imag-
ing, the size of the bore is notable since it determines the extent of distortions at the fringes of
images.
A primary lung MRI protocol (with essential parameters shown in Table 1) was designed
for the in vivo study based on a clinical routine protocol optimized to deliver the best achiev-
able diagnostic information on lung structure and function in COPD patients [3, 24]. This was
then adjusted by the coordinating centre for each scanner hardware configuration, varying in
parameters including resolution, echo time, repetition time (TR) as well as the degree of accel-
eration by parallel imaging. Since SNR and measurement time are so limited in lung imaging,
it was necessary to optimize sequences with regard to diagnostic quality, in general on the cost
of comparability between scanner models and software versions. Parameters were also chosen
to minimize the number and length of breath-holds for patients, exploiting the capabilities of
each scanner. However, these adjustments were kept as small as possible and the same protocol
was used on identical scanner configurations. This approach is currently used in most multi-
centre lung imaging studies using 1H-MRI techniques, since due to the limited SNR, it is man-
datory to produce as many diagnostically useful images as possible instead of maximizing
effective inter-scanner variability on the cost of SNR. In this context, it is not useful to adjust
Table 1. Sequence parameters of the study protocol used on the Siemens Aera Scanners for in vivo measurements and phantom measurements.












VIBE 3D cor 3.61 1.63 400×400 4.0 1.39×1.39 288×288 2 0:16
VIBE 3D tra 3.29 1.61 400×300 4.0 1.25×1.25 320×240 2 0:16
HASTE 2D cor 314.0 20.0 400×400 6.0 0.78×0.78 512×512 3 0:13
HASTE 2D tra 500.0 27.0 450×366 8.0 1.41×1.41 320×260 2 0:35
TrueFISP 2D cor 448.9 1.17 400×400 4.5 0.78×0.78 512×512 3 2:20
BLADE 2D cor 905.0 73.0 400×400 6.0 1.25×1.25 320×320 2 2:13
HASTE IRM 2D tra 502.0 72.0 400×400 6.0 1.56×1.56 256×256 2 0:38
Angio 3D cor 2.80 1.04 350×400 1.8 1.04×1.04 336×384 3 0:16
TWIST 3D cor 1.73 0.76 366×450 5.0 1.76×1.76 208×256 2 0:37
VIBE FS 3D tra 3.29 1.61 400×300 4.0 1.25×1.25 320×240 2 0:17
Shown are excitation mode, slice/slab orientation, repetition time, echo time, field of view, voxel size, image matrix, parallel imaging factor and total acquisition time.
Note that the in vivo study contains additional repetitions of identical sequences in different respiratory states as well as after contrast agent injection.
https://doi.org/10.1371/journal.pone.0199148.t001
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scan parameters on all available scanners to match image quality of the least capable scanners.
As such, the phantom measurements shown here reflect both differences in scanner hardware
directly as well as the sequence parameters applicable due to that hardware.
Phantom design and fabrication
Several requirements were defined for the proposed phantom: To allow for manufacturing a
number of phantoms and sending one to each study centre, any single instance should be suffi-
ciently cheap to produce as well as small enough for regular mail transport. For the phantom
measurements to be practical, they would have to be performed by the trained technicians on-
site using the original protocol designed for the study and be appropriately simple to handle.
Thus, both differences in scanner hard- and software as well as the protocol parameters would
be considered as they affect patient images. Tissue categories encountered in lung imaging
should be emulated by the phantom, especially the lung parenchyma.
The phantom was chosen to simulate four tissue groups significant for lung imaging:
Blood, muscle/thoracic walls, fat and the lung parenchyma itself. Compartments for each
phantom instance were produced using rectangular 250ml HDPE bottles, measuring
114×76×48mm, as shown in Fig 1.
For the blood compartment, a solution of 0.5mmol/l NiSO4 was intended to provide a T1
relaxation time similar to blood while also allowing for liquid consistency. For the muscle/tho-
racic wall, a 4% agar-agar preparation with 1.2mmol/l NiSO4 was used. Once the agar cools
after having been heated to above 95˚C, this results in a gelatinous material, which was again
adjusted for T1 using NiSO4. This was cast around a 6mm diameter acrylic rod placed diago-
nally inside the phantom bottle to provide a structural element with reproducible position and
size within the phantom.
The fat compartment contains canola (rapeseed) oil, which was closest in T1 to the desired
value, even though this means the fat in the phantom is liquid, unlike in vivo. This was chosen
Fig 1. Photo of a phantom instance.
https://doi.org/10.1371/journal.pone.0199148.g001
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since the study protocol includes fat suppression using an inversion recovery STIR-sequence
as well as gradient echo sequences that utilize spectral fat saturation.
To have some way to estimate contrast- and signal-to-noise ratios in the lung parenchyma,
a phantom compartment that emulates the high inhomogeneity of the magnetic susceptibility
and low proton density in the lung is required. To approximate the structure of alveoli, which
have a diameter of about 200μm, a mixture of 500μm and 100μm diameter glass beads at a
mass ratio of 4:1 was used. On these, a mixture of heated 2% agar-agar and 0.5mmol/l NiSO4 is
poured and stirred thoroughly. Since the glass beads do not have a uniform size, they would
separate due to size segregation when shaken if the surrounding solution were fluid [25, 26],
which is prevented by the agar. Further, in order to reduce the amount of air bubbles in the
resultant gel, it was set up to cool slowly by placing the bottles in a water bath heated to 60˚C-
80˚C, giving bubbles time to rise out of the gel. As for the blood and muscle compartments,
the concentration of NiSO4 was chosen to achieve a T1 comparable to lung tissue in COPD
[27]. Each bottle was labelled according to its contents, with a ‘poison’-notice if it contains
NiSO4 and the date of its fabrication or filling. For each phantom instance, one of each com-
partment was manufactured and taped together in identical configuration.
The present study was solely based on phantom measurements and did not involve human
participants, specimens or tissue samples, or animals, embryos or tissues. Therefore, the study
does not require ethical approval.
Measurements
To verify the appropriateness of the phantom design, T2 in the compartments of one phan-
tom instance was measured using a 2D ultra-short TE (UTE) multi-echo sequence [28]: Signal
was acquired at TE1-5 = 70μs, 0.50ms, 1.20ms, 1.65ms, 2.30ms, 9.53ms, 14.3ms and fitted to
an exponential decay function. T1 was quantified using a radial look-locker inversion recovery
sequence [29] with temporal resolution 18.6ms and 3s maximum inversion time.
At 15 centres, four different scanner models from the same vendor (Siemens Medical,
Erlangen, Germany) were used: Avanto, Aera, Espree and Trio. Aera, Avanto and Espree pro-
vide main fields of B0 = 1.5Tand the Trio has B0 = 3.0T. While the only relevant difference
between the Avanto (dB,Avanto = 60cm, lB,Avanto = 150cm) and Espree (dB,Espree = 70cm, lB,Espree =
120cm) is that the Espree’s bore is wider and shorter, the Aera (dB,Aera = 70cm, lB,Aera = 137cm)
has bore dimensions between the two and a more advanced set of receive coil arrays with a
larger number of coils (e.g. body arrays with 18 rather than 6 coils, spine arrays with 32
rather than 18 coils). Also, the Aera scanners and one Avanto use newer generation software
(VD) than the others (VB), which differs with regards to image acquisition and reconstruction.
Accordingly, the parallel imaging capabilities vary significantly between these two groups
of scanners and two slightly different sets of protocol parameters were chosen for the in vivo
study.
For each of these scanner models (except the Trio), there is one version with a gradient sys-
tem capable of 33mT/m and one with 45mT/m in use, which, in the case of the Avanto sys-
tems, was also equipped with a receive amplifier with a lower number of channels.
The imaging protocol for the in vivo study was designed to provide diagnostic information
on lung structure and function, similar to protocols in cystic fibrosis, but optimized for
COPD=patients [24]. As such, it includes sequences of several types: T1-weighted gradient
echo sequences (VIBE) with minimal echo times, half-Fourier turbo spin echoes (HASTE),
T2-weighted radial TSE (BLADE), balanced steady state free precession (TrueFISP) and addi-
tional gradient echo sequences intended for angiography and for dynamic perfusion quantifi-
cation (TWIST). While most of these sequences are acquired in coronal orientation, the VIBE
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and HASTE are repeated in transverse orientations with near-identical parameters. Finally,
two different types of fat-suppressed methods are employed: A transverse HASTE image using
short TI inversion recovery (STIR) and transverse VIBE using fat saturation pulses. Except for
the TrueFISP, all sequences are acquired during breath-holds in vivo and thus have acquisition
times shorter than 20s or are split into several such acquisitions.
In the in vivo study, the most relevant biomarkers derived from the above mentioned MRI
acquisitions were visual scores (3-point rating scale, lobe based assessment) for 1) the extent of
airway wall thickening/bronchiectasis, mainly based on pre-contrast VIBE sequences in coro-
nal and transverse orientation 2) the extent of parenchymal defects (emphysema) based on
structural MRI sequences (mainly HASTE sequences in coronal and transverse orientation),
and 3) the extent of perfusion defects (visually perceivable defects at time point of peak
enhancement in subtracted coronal TWIST images) as well as quantitative software-based per-
fusion parameters (pulmonary blood flow (PBF), pulmonary blood volume (PBV), mean tran-
sit time (MTT)). Other visual biomarkers are the extent of mucus plugging (HASTE, coronal
and transversal) and the extent of peribronchial nodules reflecting bronchilitis (HASTE and
contrast enhanced VIBE, each cor + trans). Each of these biomarkers is assessed semi-quanti-
tatively with a visual 3-point rating scale. The BLADE sequence serves as alternative in case the
HASTE sequences are unusable due to artifacts. The HASTE irm provides T2 weighted images
with fs, and is mainly used to further characterize incidental findings in synopsis with the
other sequences. The Angio FLASH sequence is used to exclude pulmonary embolism, which
is mandatory when interpreting the dynamic TWIST perfusion study. The free-breathing
TrueFISP was added to the protocol since it is robust to motion artifacts and allows to estimate
respiratory mechanics.
For the phantom measurements, the intended breathing state is of course irrelevant and
each measurement was performed with 5s delays in between to ensure relaxation. Just as the
patient measurements in the in vivo trial are necessarily performed by different teams of tech-
nicians at each site, phantom measurements were also completed by the local technicians
according to precise instructions provided together with the phantom instances. Phantom
measurements were acquired at baseline of the in vivo study, and, as far as possible, repeated
every 3 months for as long as patient data was acquired at each individual site, resulting in
between 1 and 5 phantom measurements each.
The parameters in use both for the in vivo study and the phantom measurements given in
this work are shown in Table 1. Note that these are given for the measurements on Aera scan-
ners and that the parameters used on the other systems were slightly different. These choices
were necessary to optimize for image quality in the lungs, while adapting to the different gradi-
ent and main field strengths as well as the receive coils available at each study centre as men-
tioned above.
Image data analysis
Image parameters were determined from a set of MR images measured using the unmodified
base protocol for the multicentre study, removing only automated breathing commands. The
images were processed using custom software written in Python for this purpose. All parame-
ters were evaluated separately for each MR sequence.
Since it provides comparatively high SNR and resolution at minimal sensitivity to artefacts,
the first step of locating the phantom bottles in the images was completed in the first image
series, which is a coronal GRE. One annotated slice of this is shown in Fig 2a. The phantom
bottles are detected using a watershed [30] on the sum of all slices of the 3D acquisition, with
the bottom of the bottles determined from a second transverse projection using a simple
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threshold. The top of each compartment is finally cut off exploiting the known dimensions of
the bottles, since the uppermost layer in the lung-like compartment tended to be inhomoge-
neous due to the fabrication procedure. Since the lung compartment was made of glass beads
of different sizes being fixed in agar containing NiSO4, a small amount of supernatant mainly
containing agar developed above the glass bead layer during the cooling and solidification pro-
cess. This layer does not have the attributes of T2 and proton density desired for the simula-
tion of lung parenchyma. Due to T1-weighting, compartments were easy to identify by their
relative signals in the GRE image, giving an association of each voxel to a specific compartment
(or background). For the images of all other sequences, this 3D association map was used by
deforming and transposing it according to the position and pixel spacing information taken
from DICOM tags of both images.
While this association map provides signal amplitudes for each compartment and sequence,
signal-to-noise and contrast-to-noise ratios require a measure of noise for normalization.
Unfortunately, in the available DICOM images, noise is highly inhomogeneously distributed
and cannot be properly quantified in the outward regions of the images since they are stored
as 12-bit integers, which results in background areas consisting in large parts of just zeroes and
ones. Thus, to provide a reasonable estimate of noise, a simple 3-dimensional edge detection
kernel was convolved onto the image to determine local variations. All voxels above a thresh-
old in this convolved image were considered to be actual edges in the original image, while
zeroes were assumed to be part of areas with undetectable noise due to the integer representa-
tion. Ignoring these voxels, the standard deviation σn of the remaining voxels in the convolved
images was used as noise estimate and used together with the association map to calculate an
SNR value for each sequence and compartment. CNR values for each sequence and pair of
compartments were determined from the signal difference divided by σn.
Two separate measures were implemented to reflect structural depiction: The shape of the
acrylic rod as it appears in images and the reproduction of the phantom bottles’ edges. For the
rod depiction, the rods position is first determined by detecting contours below a threshold in
the already found ‘muscle’ compartment. Since the rod is always straight, its orientation can
then be identified using a simple linear fit. From this, the signal gradients orthogonal and
Fig 2. Gradient echo and turbo spin echo MR images of the phantom. a: A single, central slice of a 3D VIBE acquisition
showing all phantom compartments. b: A slice acquired using HASTE. Slices are equivalent to coronal orientation.
https://doi.org/10.1371/journal.pone.0199148.g002
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parallel to the rod’s orientation projected into the imaging slice are determined. These each
correspond to the representation of the rod cross section within the slice and the slice profile,
respectively. To reduce these curves to a single number, the Full Width at Half Maximum
(FWHM) is calculated.
Additionally, the edge representation of each sequence is determined in the two orthogonal
directions within each image set. To do so, the centre of each compartment is calculated from
its centre of mass and the signal gradient orthogonal to the two outside edges of the bottle,
starting from this centre, is averaged in a small strip. Again, a single number for each direction
is achieved by fitting a sigmoidal function to this gradient and using the width of the sigmoid
as the measure of edge blurring.
Statistics
The results below are given as mean ± standard deviation unless otherwise stated. As measures
of repeatability, standard deviations between the quality measures determined from multiple
measurements were computed. To examine the statistical significance of the differences found
between the scanner models in use, p-values were calculated using the Mann-Whitney U test,
whereby p-values below 0.05 were considered significant.
Results
According to the UTE measurement, the transverse relaxation times in the phantom were
T2L = (2.05±0.26)ms for the lung compartment and T2F = (10.00±0.16)ms, T2M = (32.5
±0.59)ms, T2B>100ms for the fat, muscle and blood compartments, respectively. While this
T2 for the lung compartment is still longer than what has been found in vivo (1.5ms, [28]),
this was considered sufficiently short to replicate susceptibility effects.
The T1 measurement gave T1L,F,M,B = (871±41)ms, (183±6)ms, (762±13)ms, (1377±23)ms
for each compartment. T1 in the lung compartment is still somewhat shorter than what has
been found in the lungs of COPD patients previously [31]. However, lung T1 strongly depends
on the state of the lungs and thus is generally lower in COPD patients with worse disease and
varies strongly between patients. Accordingly, this was considered acceptable. Notably, while
producing shorter T1 is easily possible, providing both longer T1 and maintaining the desired
T2 is difficult.
For short-term intra-scanner variability, repeated measurements (n = 5) of the same phan-
tom on the same scanner unit provided low relative standard deviations in SNR for each com-
partment, in particular 4.5% for lung tissue, 4.0% for blood, 3.3% for muscle, and 3.7% for fat.
A total of 12 phantom instances was produced, and a certain inter-instance variability had
to be expected since all instances were hand-made prototypes. Thus, inter-instance variability
had to be assessed. In this context, the comparative measurements of the 12 phantom instances
on the same scanner revealed an average relative standard deviation in SNR of 12.2% for the
lung compartment, 3.2% for blood, 6.7% for muscle and (excluding bSSFP, which exhibits
characteristic banding artefacts and fat-suppressed sequences, where SNR for fat is purposely
minimal) 2.7% for fat.
Measuring all 15 scanners using 12 phantom instances (at baseline of the in vivo study),
SNR values ranged from 1.360±0.055 for the lung compartment in the Angio FLASH sequence
to 174.0±3.6 for the blood compartment in the transversal HASTE sequence. Table 2 shows
SNR averaged over the mean in the baseline measurements as well as the standard deviation
between these values are for all sequences in the study protocol.
When we performed the initial phantom measurements across all 15 imaging sites (using
12 phantom instances) upon the start of the in vivo study, the inter-scanner-variability in SNR
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was found to be significantly larger than the abovementioned short-term intra-scanner and
also inter-instance variability. For example, in the BLADE sequence, inter-scanner variability
ranged from 7% in the fat compartment to 56% in the blood compartment. In general, for
most of the sequences in the study protocol, the lung compartment provides the largest inter-
scanner variation, between 31% in the coronal HASTE and 62% in the TWIST (disregarding
the Angio FLASH sequence which has too little SNR to be reasonably compared). Overall, the
average relative difference in SNR to the median was 41% for the lung compartment, 32% for
blood, 27% for muscle and 32% for fat.
Fig 3 shows the quartiles of the SNR found for the coronal VIBE sequence in all compart-
ments as well as SNR in the lung compartment only for the HASTE, TWIST, TrueFISP and
BLADE sequence. Note that values are not only sorted by scanner types, but that for all types
except the Trio there is one device with a weaker gradient system. While longitudinal measure-
ments were acquired for each study site at 3 month intervals, only the baseline measurements
are shown here to ensure clarity and comprehensibility.
Several follow-up measurements at 3 month intervals were available for most scanner units,
providing 3–5 measurements for each of the Aera, 2–5 for the Avanto, 2–6 for the Espree sys-
tems, and 3 for the Trio system. When considering all available measurements (i.e. initial
phantom measurements across all 15 imaging sites at baseline of the in vivo study, and addi-
tional follow-up measurements), the differences in SNR apparent in Fig 3 can be examined sta-
tistically: Comparing SNR in the VIBE sequence and the lung-equivalent compartment yields
p<10−4 for the differences between the Aera systems and each of the Avanto, Espree and Trio
groups. Conversely, among the Avanto, Espree and Trio groups, the test gives p>0.05. While
the 3T system, the Trio tends to provide notably different values than the 1.5T systems in sev-
eral parameters, the divergence is not statistically significant due to the small number of mea-
surements available on the 3T system.
Comparing the otherwise identical T1-weighted sequences with and without fat suppres-
sion pulses, the suppression effectiveness given as the relative reduction of signal was found to
be 87.0%±3.7% on average, reflecting mainly the local B0 homogeneity.
Fig 4 shows the profile widths detected in three selected sequences, reflecting the depiction
of structures: The VIBE, HASTE and TWIST measurements, all acquired in coronal orienta-
tion. The values represent a single time point (measurements performed at baseline of the in
vivo study) and are ordered by the different scanner types used. The upper and centre rows
contain the detected apparent width of the acrylic rod in the phantom, both within the imaging
plane and perpendicular to it (through-plane). Again, the statistical tests for the difference
Table 2. Mean and standard deviation of SNR over all 15 scanners measured at baseline of the in vivo study using
12 phantom instances, ordered by sequence and phantom compartment.
Sequence Lung Blood Muscle Fat
VIBE cor 6.1±3.5 30.3±13.2 39.6±18.4 49.9±24.3
VIBE tra 6.5±3.3 33.3±12.3 42.1±16.7 52.8±20.3
HASTE cor 18.7±9.4 215.4±85.3 81.4±28.2 166.2±60.7
HASTE tra 26.5±13.7 234.6±99.1 99.4±41.4 176.6±74.5
TrueFISP 4.4±2.7 112.3±55.6 32.3±20.6 58.8±24.9
BLADE 3.0±1.7 118.2±81.0 12.3±3.9 75.7±24.2
HASTE IRM 4.8±2.5 125.5±30.5 15.7±6.8 4.4±2.3
Angio 1.2±0.3 2.8±1.6 4.9±2.7 15.4±3.6
TWIST 3.0±2.2 8.5±5.2 13.6±8.0 51.7±32.7
VIBE FS 3.9±2.0 29.9±8.7 39.4±15.2 12.6±7.9
https://doi.org/10.1371/journal.pone.0199148.t002
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between the scanner types were applied on all available measurements (i.e. baseline measure-
ments and subsequent follow-up measurements at 3 month intervals), yielding p<0.05 only
for the difference between the Espree and Aera, as well as Espree and Avanto. Similarly, struc-
ture and edge representation measures in the other sequences and directions were found to be
significantly different among several of the scanner types in use.
Average edge widths were found to range from (1.79±0.71)mm in frequency- and (2.83
±0.50)mm in phase-encoding direction in the coronal VIBE to (1.49±0.70)mm and (11.4±1.7)
mm in coronal HASTE images. Regarding structural depiction derived from the apparent
width of the acrylic rod, the difference between 45mT/m and 33mT/m gradient systems was
notable, with the largest discrepancy of, on average, (4.1±2.3)mm to (7.7±4.0)mm, which was
significant at p = 0.02 in the combined analysis of baseline and follow-up measurements.
Discussion
Quantitative lung imaging in a multicentre environment warrants standardization of image
quality as far as possible. This is addressed in all current multicentre studies with CT. Stan-
dardization procedures are constantly refined for example by the Quantitative Imaging Bio-
markers Alliance (QIBA) [32], the SPIROMICS initiative [33], or SCIFI CF (Standardised
Chest Imaging Framework for Interventions and Personalised Medicine in CF) [14]. While
Fig 3. SNR obtained from all 15 scanner units (using 12 phantom instances) for the coronal VIBE sequence, sorted by MR scanner type and phantom
compartment (a-d), as well as SNR for the HASTE, TWIST, BLADE and TrueFISP sequences, given for the lung compartment only (e-h). Scanners using 33mT/m
gradient systems are marked using stars. Please note that only the initial phantom measurements acquired at baseline of the multicentre in vivo study are shown. Data
from follow-up measurements performed at 3 month intervals were left out to maintain clarity.
https://doi.org/10.1371/journal.pone.0199148.g003
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the measurements discussed here were being performed, the SPIROMICS initiative suggested
to use standardized imaging protocols with additional scanning of standardized test objects
(phantoms) at regular intervals to ensure protocol consistency and estimate comparability of
image-based biomarkers across multiple centres. With regard to MRI in the lungs, methods to
standardize image quality across multiple scanners are less developed, and commercially avail-
able reference phantoms focus on tissues with completely different signal characteristics than
lung tissue [15–19]. Due to a lack of commercially available products suited specifically for
morphological and functional in vivo 1H-MRI of the lung in multicentre patient studies, we
aimed to design and apply a dedicated MRI reference phantom to detect and quantify diverg-
ing SNR and CNR of lung and chest tissue components with different MRI scanner models.
This bears relevance, since heterogeneous equipment with diverging design and software is
nearly inevitable when performing imaging in large in vivo multicentre studies as observed in
multicentre CT [13, 34] and MRI [8, 24] based lung imaging studies, potentially influencing
assessment and interpretation imaging data/biomarkers. With regard to multicentre MRI and
also CT it is nearly impossible to adjust the various scan parameters in a way that scanners of
different design and software provide completely identical image characteristics. Especially in
MR imaging, it would mean to adjust image quality towards the level of the least capable scan-
ners. This is important since the lungs provide only poor signal, and it is difficult to obtain
images with sufficient quality to discriminate pulmonary physiology and pathology.
Fig 4. In-plane (a) and through-plane (b) profile widths detected in three selected sequences, sorted by site and scanner type. While the actual diameter of the rod is 6mm,
these values are derived from the FWHM of a fitted function and thus should be smaller. (c) Shows the edge widths detected at the muscle-equivalent compartment in
phase encoding direction. Hatched bars represent MR scanners with 33mT/m gradient systems. Please note that only the phantom measurements acquired at baseline of
the in vivo study are displayed here.
https://doi.org/10.1371/journal.pone.0199148.g004
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Consequently, current MRI studies usually define a base protocol which is modified to the
capabilities of individual MRI scanners, instead of maximizing effective inter-scanner variabil-
ity on the cost of SNR. Such adjustments of the base protocol can also contribute to heteroge-
neity and have to be addressed together with other previously mentioned determinants of
image quality.
Since lung MRI is complicated by extremely short T2 relaxation times [22] and very low
proton density, only comparatively low spatial resolutions are achievable in lung MRI. Accord-
ingly, the design of our phantom was not focused on the depiction of small details, thus allow-
ing for a cost-effective design. Since the necessity of having measurements performed by
technicians on site using the given study protocol is a limiting factor, the design shown and
examined here also prioritizes ease of use over precision.
Repeat measurements for short-term intra-scanner variability showed a fairly good repro-
ducibility of the measurement of one phantom instance on the same scanner with variabilities
below 5%. Due to limited precision in the manufacturing process, the inter-instance variability
(of the 12 instances produced) on this scanner is slightly larger, between 3.2% and 12.2%. Still,
the individual phantom instances were considered sufficiently comparable to observe inter-
scanner variability across multiple centres. The measures of image quality determined using
the phantoms display substantial differences between the examined scanner systems at the
respective study centres, both among scanners of the same type and, more noticeably, between
different scanner types. Importantly, for most of the MRI sequences, SNR measurements of
the phantom´s lung compartment showed far higher inter-scanner variability compared to the
muscle, fat or blood compartment. Notably, the divide between the Aera systems and other
scanners visible in Figs 3 and 4 reflects not only the physical characteristics of the systems, but
also the different generations of the software running on the scanners. Additionally, note that
the signal and noise distributions gained from each compartment can also be used to deter-
mine contrast-to-noise ratios between each pair of compartments, as reported in the supple-
ment (see S1 Text).
While the profile widths shown in Fig 4 primarily reflect the difference between the avail-
able scanner software versions, the through-plane profiles also highlight the effect of the gradi-
ent system available on each scanner. Since lung MRI relies on short echo times to maximize
signal, gradients are used to their full extent. Since the TWIST measurement is used for
dynamic contrast enhanced perfusion analysis, high temporal resolutions and thus fast mea-
surement times are relevant as well, requiring the use of coarser resolutions on scanners with
weak gradient systems, which is well recognized by increased through-plane profile width as
observed in the phantom measurements.
Since, as stated above, the difficulties of lung imaging lead to optimizing acquisition param-
eters for image quality rather than comparability, both image resolutions and parallelization
ratios differ significantly between the scanners models in use. Accordingly, the calculated pro-
file widths and SNR values alone do not provide a complete measure of image quality, but
should provide sufficient quantitative information to estimate the variability of image quality.
By analogy to previous multicentre CT studies with pulmonary imaging, we observed sub-
stantial inter-scanner variability in a typical setting of multicentre lung MRI. Other research
groups who were concerned with image quality in multicentre MRI studies focused on other
organs than the lungs, but also observed substantial inter-scanner variability: Colombo et al.
investigated the variability of 12 MRI systems from 0.5T to 1.5T in a multicentre setup. They
investigated short- and mid-term variability of SNR and image uniformity (U%) using a spin
echo sequence and a simple 20–24 cm phantom body filled with paramagnetic fluid (relaxation
time in clinical range). Imaging of the phantom was repeated at baseline and 24h later and sub-
sequently twice a week for 5 weeks. SNR and U% values showed significant differences among
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the scanner units. The results of the 24h measurements did not show significant heterogeneity
during daily time interval for all the devices. In longitudinal measurements they observed a
variability of 3% of the reference level for both parameters [35].
Belli et al. designed and applied a cylindrical doped water reference phantom for multi-
centre comparison of different MR scanners for quantitative diffusion-weighted imaging in
twenty-six imaging facilities using 35 MR scanners with field strengths between 1T and 3T.
Mean apparent diffusion coefficient (ADC) values were calculated and a significant differ-
ence between 1.5T and 3T was observed for high b-values. Short-term repeatability of ADC
measurement (5 measurements, 1 minute delay each) was found <2.5% for all MR scanners
[36].
In the US, the wide-spread MRI accreditation program of the American College of Radiol-
ogy (ACR) evaluates the qualifications of personnel, the quality control program, MRI safety
policies and image quality [37]. The accreditation test requires the acquisition of phantom
images, and 2 different MRI phantoms are available from the ACR depending on the scanner
unit. Employing an ACR phantom, Fu et al. investigated inter-site variability in SNR, image
uniformity, width and height [17]. Mean SNR, image uniformity, width and height showed
significant variability among the different scanners.
Harmonizing lung imaging biomarkers across multiple centres is challenging with CT, but
is even more complicated with MRI, not least as the MR signal itself is not normalized to phys-
ical tissue characteristics as are density values in CT. Reference phantoms as demonstrated in
the present study allow for a rough but objective estimation of inter-scanner variability, open-
ing up several opportunities for handling inter-scanner inconsistencies: One possible way
would be to test the scanners at potential imaging sites already in the planning stage of a clini-
cal multicentre study with appropriate phantoms and exclude scanners or even imaging sites
which show substantial downside deviation or do not reach a certain pre-defined quality
threshold. Notably, phantom measurements cannot improve images of insufficient quality. In
this process, the focus should be on image quality related parameters which are most critical
for the respective in vivo study. Not only main field strength, but also gradient system, software
version (which in this case also determines receive coils), bore dimensions and number of
available receive channels should be considered.
When performing in vivo imaging within large networks or cohort studies (as in the present
study), it is a common problem that imaging centres with heterogeneous equipment have to
be included. In such cases, the true extent and underlying causes of inter-centre variability of
imaging biomarkers are a matter of speculation, unless phantom measurements are available
providing objective measures of variability. Differences in scanner hard- or software should be
regarded as the underlying cause of such inconsistencies if MRI biomarkers (for example
emphysema score) and phantom measurements (for example SNR) are strongly correlated
and if both show a high variability between different centres. This could potentially bias com-
parison of imaging biomarkers with clinical tests, for example when correlating emphysema or
perfusion scores and genetics. In such cases, in vivo datasets from scanners with substantial
(downside) deviation compared to the mean of all available scanners could be excluded from
statistical analyses, if relevant. However, this is certainly not cost- or time effective. As alterna-
tive approach with comparatively low drop-out rate, a standardization of biomarkers using z-
transform can be attempted, but it requires normally distributed data and large sample size.
Data harmonisation of imaging biomarkers using other mathematical procedures such as
regression models or machine learning algorithms based on quantitative phantom measures
are still of experimental character. Concerning quantitative lung perfusion biomarkers such as
the pulmonary blood flow, absolute numbers of such perfusion indices could be replaced by
measures of regional perfusion heterogeneity (variance), which should be less susceptible to
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inter-scanner variability. The limitations of the present reference phantom for the depiction of
lung MRI measurements are significant: While lung signal is strongly influenced by the flow
of blood, the phantom does not implement simulated perfusion. In particular, the contrast-
agent based dynamic perfusion measurement included in the study protocol cannot be fully
addressed this way. Of course, implementing this in a phantom would be more expensive and
complex. Further, due to the compact design the phantom reflects the influence of different
bore-sizes or macroscopic field homogeneity only to a limited degree [38]. Macroscopic field
homogeneity is of relevance in lung imaging, and can only be addressed with phantoms of ade-
quate size (app. 50cm×50cm×40cm), ideally with anatomically shaped units. Unfortunately,
the mass and material cost of a phantom grows with the 8th power of each dimension, assum-
ing the same construction as in the present study. In consequence, high costs as well as diffi-
culty with production, transport, storage and handling would have to be expected. However,
lighter or cheaper components are still not available for MRI phantom production. As we
could not find a reasonable option to cover the entire relevant Field of View, in this work we
chose to focus on the signal characteristics in the isocentre of the scanner. By analogy, contem-
porary established CT reference phantoms such as the COPDGene2 test-object [39] or com-
mon quality assurance phantoms such as the CatPhan [40] also cover only a small field-of-
view, while inhomogeneity of SNR throughout the FOV can also be found in CT imaging [41,
42].Determining image noise for SNR calculations accurately from a single MR measurement
on its own is challenging as described above in the methods section. Simply put, because of the
coil sensitivities and the image reconstruction process, image noise is very low, with markedly
heterogeneous distribution, while the noise of the individual coils is correlated with each
other. For a more accurate noise measurement, the extent of noise of the individual coils
would have to be assessed, and measurements without excitation pulses would have to be per-
formed. However, both is too complex to be achieved at multiple centres with trained techni-
cians performing measurements at 3 month intervals. Image characteristics of the 3T scanner
tended to be different from the other scanners. However, statistical significance could not be
found since there was only one such scanner included in this study with a small number of
measurements. Nonetheless, we considered it noteworthy due to the novelty of the study sub-
ject. Besides, the present study included only scanners from a single manufacturer since the
scanners were employed in the overarching in vivo study for which the phantom was designed.
Hence, inter-vendor variability could not be investigated. The monitored timespan does not
yet provide enough data to confirm that the phantoms’ MRI parameters remain constant
over several years, which would be long enough for applicability in a potential long-term fol-
low-up study. Nevertheless, the phantom experiments shown support a notable influence of
the choice of MRI scanners on the homogeneity of image quality in the multicentre study.
Given the very wide range of scanner models employed and investigated here, the validation of
the phantom should be applicable for other multicentre lung MR studies. Further development
will be necessary to improve accuracy and allow for a profound assessment of functional MRI
acquisitions.
Conclusion
The presented reference phantom allows to reproducibly quantify relevant metrics of image
quality in multicentre in vivo studies using contemporary proton MRI protocols for lung imag-
ing. Even when making efforts to create a fairly uniform scanner assortment suitable for lung
imaging, substantial inter-centre variability is inevitable when employing scanner types with
diverging design or software, and can even be found among the same scanner models due
different hard- and software specifications. Besides, objective measures of inter-scanner
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variability can only be achieved with reference phantoms specifically designed for lung MRI,
and the data can be helpful to detect or maybe overcome bias in the interpretation of study
results. Finally, comprehensive standardization of lung MRI biomarkers remains a challenge.
Supporting information
S1 Table. Device attributes of the scanner models used.
(PDF)
S2 Table. Sequence parameters on 4 different scanner models. Note that for all models
except the Trio there is an additional modified protocol for the version with weaker gradient
system, which requires different TE and TR.
(PDF)
S3 Table. CNR between the individual phantom compartments. These are (measured across
all 15 scanners with 12 phantom instances) at study baseline. This is the mean and standard
deviation of the median CNR found in each measurement.
(PDF)
S4 Table. Signal ratios between the individual compartments, analogous to S3 Table.
(PDF)
S1 Fig. Examples of profile and edge depiction quantification. a,b: To determine profile
depiction, signal parallel (a) to the 6mm acrylic rod’s passage through slices and orthogonal
(b) to it is fitted with a gauss curve in each slice where it is visible. The full width half maxi-
mum of the curve is used as a measure of structural depiction, averaged over all slices. Only
one slice of the coronal HASTE is shown here. c,d: To determine edge widths, an offset sigmoi-
dal function α/(1+exp((x-β)/γ))+δ is fitted to the signal perpendicular to the edges in the
image. γ is used as a measure of edge blurring, while the other fit parameters are discarded.
Note the shape of the edge in the muscle compartment (short T2) in c and d.
(SVG)
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